Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ZeroStack ( (ZSTK) ) just unveiled an update.
ZeroStack Corp., the first Nasdaq-listed AI-focused asset manager that also runs a global pharmaceutical distribution arm, is deepening its presence in decentralized AI ecosystems through blockchain-based yield strategies. By leveraging its exposure to 0G, the native token of a decentralized AI operating system, the company blends digital asset returns with its traditional distribution operations to broaden its revenue mix and investor appeal.
The company reported earning 3.2 million 0G tokens in staking rewards since January 21, 2026, equivalent to about $2.2 million over the period and implying a roughly 22% annual percentage yield based on recent prices. Management said the 0G staking position has become a core portfolio anchor, delivering roughly $50,000 per day in rewards, underscoring ZeroStack’s strategic bet that blockchain staking yields in decentralized AI networks can be a significant and recurring income stream as institutional interest in such opportunities grows.
The most recent analyst rating on (ZSTK) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on ZeroStack stock, see the ZSTK Stock Forecast page.
Spark’s Take on ZSTK Stock
According to Spark, TipRanks’ AI Analyst, ZSTK is a Neutral.
The score is primarily held down by weak financial performance: sharp revenue decline, ongoing losses, persistent negative free cash flow, and a significant 2025 increase in debt. Technicals are mixed with neutral momentum but a weak longer-term trend, while valuation offers limited support given the negative P/E and no dividend yield.
To see Spark’s full report on ZSTK stock, click here.
More about ZeroStack
ZeroStack Corp. is a Nasdaq-listed asset management company focused on providing investors exposure to decentralized artificial intelligence assets, while also operating a global pharmaceutical distribution business through its wholly owned subsidiary Phatebo GmbH. The firm positions itself at the intersection of AI, blockchain-based financial products and traditional healthcare supply chains, targeting both institutional and diversified global markets.
Average Trading Volume: 108,779
Technical Sentiment Signal: Sell
Current Market Cap: $16.99M
For a thorough assessment of ZSTK stock, go to TipRanks’ Stock Analysis page.